1 62100sek
-0,8 %
Date:2025-10-10Time:18:00:00Latest report:Q2-2025List:Large CapTicker:AZN
Market Cap:2 513 673 msekEnterprise Value:2 752 263 msekNet Sales:56 501 musdEarnings:8 295 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 621,00
MA50:1 497,69
MA200:1 453,47
Price/MA200:11,5 %
RSI (14):70,9
Price/MA50:8,2 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.

Pharmaceuticals